Dk. Newman et al., PREVENTION OF IMMUNE-MEDIATED CORNEAL GRAFT DESTRUCTION WITH THE ANTILYMPHOCYTE MONOCLONAL-ANTIBODY, CAMPATH-1H, Eye, 9, 1995, pp. 564-569
We report a patient with peripheral rheumatoid corneal melting who dev
eloped a corneal perforation in one eye requiring tectonic keratoplast
y. Nine consecutive corneal grafts were rapidly destroyed despite syst
emic immunosuppression with corticosteroid, cyclophosphamide, azathiop
rine and cyclosporin A. A rejection episode was observed in one graft
before it melted and allograft rejection may have contributed to the d
estruction of other grafts. Corneal graft survival was ultimately achi
eved by systemic immunosuppression with the anti-lymphocyte monoclonal
antibody, CAM-PATH-1H. A single episode of rejection developed in the
early post-operative period which was easily reversed by topical cort
icosteroid. Corneal melting has not recurred and the graft has now rem
ained intact and clear for 24 months. Anti-lymphocyte monoclonal antib
odies may therefore provide effective immunosuppression in the treatme
nt of refractory ocular disorders.